Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:

Medco, PCS Among Firms Subpoenaed In Philadelphia PBM Investigation

  • News

Executive Summary

The pressure on Rite Aid to divest PCS may create an opening for the Philadelphia U.S. attorney's ongoing investigation of the PBM industry.

You may also be interested in...



Caremark False Claims Act Settlement Could Be Framework For State Cases

Caremark's focus on resolving allegations of kickbacks and false claims related to its AdvancePCS subsidiary is expected to shift to state investigations following a $137.5 mil. settlement with federal prosecutors

Caremark False Claims Act Settlement Could Be Framework For State Cases

Caremark's focus on resolving allegations of kickbacks and false claims related to its AdvancePCS subsidiary is expected to shift to state investigations following a $137.5 mil. settlement with federal prosecutors

Lilly Zyprexa Marketing Info Sought By Philadelphia U.S. Attorney

Lilly's antipsychotic Zyprexa is among the drugs targeted in the Philadelphia U.S. Attorney's ongoing probe into prescription drug marketing practices
Table

View full table

Related Content

Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet
Tags:
UsernamePublicRestriction

Register

PS035335

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By